A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis.
Miller, David H.; Khan, Omar A.; Sheremata, William A.; Blumhardt, Lance D.; Rice, George P.A.; Libonati, Michele A.; Willmer-Hulme, Allison J.; Dalton, Catherine M.; Miszkiel, Katherine A.; O'Connor, Paul W.; New England Journal of Medicine, 2003, vol. 348, issue 1, p 15, ISSN 00284793. ISBN 00284793.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef